ROPIQUAL (ropinirole): Reviews and patient testimonials
Back to the list of medications
Medication indications
ROPIQUAL XL 2 mg prolonged-release tablets
Treatment of Parkinson's disease under the following conditions:
• Initial treatment as monotherapy, in order to delay the introduction of levodopa
• In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur ("end of dose" or "on-off" type fluctuations)
ROPIQUAL XL 4 mg prolonged-release tablets
Treatment of Parkinson's disease under the following conditions:
• Initial treatment as monotherapy, in order to delay the introduction of levodopa
• In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur ("end of dose" or "on-off" type fluctuations)
ROPIQUAL XL 8 mg prolonged-release tablets
Treatment of Parkinson's disease under the following conditions:
• Initial treatment as monotherapy, in order to delay the introduction of levodopa
• In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur ("end of dose" or "on-off" type fluctuations)
Route of administration: Oral
Molecule: ropinirole
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.